We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
World - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Report Update: Jun 1, 2025

World - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing
Dec 23, 2024

Pharmaceutical Giants Compete in Obesity Drug Market

The ongoing battle among major pharmaceutical firms to dominate the burgeoning obesity drug sector has shown dramatic movements this year. Bloomberg reports that Novo Nordisk A/S faced a challenging year with disappointing trial results, contributing to a $70 billion decrease in market capitalization. Meanwhile, Eli Lilly & Co. surged ahead, gaining over $170 billion in market value largely thanks to the popularity of its Zepbound drug.

According to data from the IndexBox platform, the global anti-obesity drug market is projected to expand significantly, fueled by the high demand and continuous innovation in drug formulation. The shift is unmistakable with smaller companies like Zealand Pharma A/S and Viking Therapeutics Inc. witnessing astonishing stock price increases of 98% and 127% respectively, as they make strides with their obesity treatments.

Performance and Expectations for Major Players

Eli Lilly, while having a prosperous year with Zepbound, now faces pressure to maintain momentum, particularly with investors eager for more data on its oral drug candidate, orforglipron, which seeks to address supply issues. Novo Nordisk's recent volatility has led Barclays Plc analysts to turn their focus towards Novo's upcoming amycretin pill, expected to be revealed in the first quarter of next year.

Amgen Inc., along with its promising, yet troubled, obesity shot MariTide, attempts to capitalize on its unique dosing schedule despite setbacks in clinical trials. Roche Holding AG, a fresh entrant, promises excitement with its new pill showing initial success in weight reduction, although facing some adverse effects.

Other players like Zealand Pharma with its petrelintide drug and Viking Therapeutics' strong trial results for both injectable and oral forms mark significant competitive threats to the current leaders. They represent the dynamic landscape that investors are trying to navigate, with partnership opportunities potentially significant in the coming years.

As businesses seek to monopolize an industry estimated by Goldman Sachs Group Inc. to reach a $130 billion valuation by 2030, the pressure remains palpable not only to deliver efficacious products but also to strategically position themselves through collaborations and innovations. The ongoing evolution in pharmacological therapies underscores a market vibrant with opportunities and rivalries, as stakeholders look towards 2025 and beyond for clarity in potential victors.

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the global medicaments containing insulin market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:

+ the largest producing countries

Data coverage:

  • Global market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Global production, split by region and country
  • Global trade (exports and imports)
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND THE AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional EditionPRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and its Prospects

    1. MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. CONSUMPTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    3. MARKET FORECAST TO 2035

  4. 4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION

    Finding New Products to Diversify Your Business

    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCTS
    4. MOST TRADED PRODUCTS
    5. MOST PROFITABLE PRODUCTS FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Export

    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. PRODUCTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)

  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    3. IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)

  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    2. EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    3. EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • United States
    • China
    • Japan
    • Germany
    • United Kingdom
    • France
    • Brazil
    • Italy
    • Russian Federation
    • India
    • Canada
    • Australia
    • Republic of Korea
    • Spain
    • Mexico
    • Indonesia
    • Netherlands
    • Turkey
    • Saudi Arabia
    • Switzerland
    • Sweden
    • Nigeria
    • Poland
    • Belgium
    • Argentina
    • Norway
    • Austria
    • Thailand
    • United Arab Emirates
    • Colombia
    • Denmark
    • South Africa
    • Malaysia
    • Israel
    • Singapore
    • Egypt
    • Philippines
    • Finland
    • Chile
    • Ireland
    • Pakistan
    • Greece
    • Portugal
    • Kazakhstan
    • Algeria
    • Czech Republic
    • Qatar
    • Peru
    • Romania
    • Vietnam

  12. LIST OF TABLES

    1. Key Findings In 2024
    2. Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    3. Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
    4. Per Capita Consumption, by Country, 2022–2024
    5. Production, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    6. Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    7. Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    8. Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    9. Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    10. Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    11. Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    2. Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
    3. Consumption, by Country, 2024
    4. Market Volume Forecast to 2035
    5. Market Value Forecast to 2035
    6. Market Size and Growth, By Product
    7. Average Per Capita Consumption, By Product
    8. Exports and Growth, By Product
    9. Export Prices and Growth, By Product
    10. Production Volume and Growth
    11. Exports and Growth
    12. Export Prices and Growth
    13. Market Size and Growth
    14. Per Capita Consumption
    15. Imports and Growth
    16. Import Prices
    17. Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    18. Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    19. Production, by Country, 2024
    20. Production, In Physical Terms, by Country: Historical Data (2012–2024) and Forecast (2025–2035)
    21. Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    22. Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    23. Imports, In Physical Terms, By Country, 2024
    24. Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    25. Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    26. Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    27. Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    28. Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
    29. Exports, In Physical Terms, By Country, 2024
    30. Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    31. Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
    32. Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)

Recommended posts

Free Data: Medicaments Containing Insulin But Not Antibiotics - World
Table
Medicaments Containing Insulin But Not Antibiotics - World - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics - World - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics - World - Report